Loading…

Effect of Polyhexamethylene Biguanide in Combination with Undecylenamidopropyl Betaine or PslG on Biofilm Clearance

Hospital-acquired infection is a great challenge for clinical treatment due to pathogens' biofilm formation and their antibiotic resistance. Here, we investigate the effect of antiseptic agent polyhexamethylene biguanide (PHMB) and undecylenamidopropyl betaine (UB) against biofilms of four path...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2021-01, Vol.22 (2), p.768
Main Authors: Zheng, Yaqian, Wang, Di, Ma, Luyan Z
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hospital-acquired infection is a great challenge for clinical treatment due to pathogens' biofilm formation and their antibiotic resistance. Here, we investigate the effect of antiseptic agent polyhexamethylene biguanide (PHMB) and undecylenamidopropyl betaine (UB) against biofilms of four pathogens that are often found in hospitals, including Gram-negative bacteria and , Gram-positive bacteria , and pathogenic fungus, . We show that 0.02% PHMB, which is 10-fold lower than the concentration of commercial products, has a strong inhibitory effect on the growth, initial attachment, and biofilm formation of all tested pathogens. PHMB can also disrupt the preformed biofilms of these pathogens. In contrast, 0.1% UB exhibits a mild inhibitory effect on biofilm formation of the four pathogens. This concentration inhibits the growth of . and yet has no growth effect on or . UB only slightly enhances the anti-biofilm efficacy of PHMB on biofilms. However, pretreatment with PslG, a glycosyl hydrolase that can efficiently inhibit and disrupt biofilm, highly enhances the clearance effect of PHMB on biofilms. Meanwhile, PslG can also disassemble the preformed biofilms of the other three pathogens within 30 min to a similar extent as UB treatment for 24 h.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms22020768